A molecular diagnostic test utilizing DNA methylation technology for early detection of lung cancer. Enables risk assessment and early diagnosis of lung malignancies through liquid biopsy methodology.
Manufactured by
China
Singlera Genomics is a China-based manufacturer of in vitro diagnostic (IVD) reagents and instruments specializing in DNA methylation-based cancer early detection and liquid biopsy testing. The company produces diagnostic products for multiple cancer types including colorectal, liver, gastric, esophageal, and pancreatic cancers, with manufacturing facilities in Yangzhou and Wuxi. Singlera holds ISO 13485 certification, CAP accreditation, US CLIA laboratory certification, and is designated as a National High-tech Enterprise in China.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
BioChain (Beijing) Science & Technology. Inc.
China · 10 relevant products
Acon Biotech (Hangzhou) Co., Ltd.
China · 2 relevant products
guangzhou biotron technolongy co.,ltd
China · 4 relevant products
HLB PANAGENE Co., Ltd.
South Korea · 2 relevant products
Clinomics Europe Kft.
Hungary · 1 relevant product
Glycanostics, s.r.o.
Slovakia · 1 relevant product
i Med Laboratories Co., Ltd.
Thailand · 1 relevant product
CheMOnitor Ltd.
Hungary · 1 relevant product
Jiangsu Sunlant Bioengineering Co., Ltd.
China · 1 relevant product
STRATEC/Diatron
Germany · 1 relevant product
44 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 84 closest product alternatives
BioChain (Beijing) Science & Technology. Inc. · China
Advanced early detection test for lung cancer screening utilizing molecular diagnostic technology. This in-development product represents the company's expansion into early detection for pulmonary malignancies. The test is designed for high-risk population screening and clinical intervention.
Acon Biotech (Hangzhou) Co., Ltd. · China
Molecular diagnostic test for cancer detection and tumor marker analysis. Supports early detection of various cancer types.
guangzhou biotron technolongy co.,ltd · China
Molecular diagnostic assay utilizing circulating tumor cell and cell-free DNA analysis to support pulmonary nodule characterization and malignancy risk assessment.
HLB PANAGENE Co., Ltd. · South Korea
A liquid biopsy diagnostic test for detection of EGFR mutations in circulating tumor DNA, supporting non-invasive lung cancer monitoring and treatment selection.
Clinomics Europe Kft. · Hungary
Multi-gene methylation detection test for colorectal cancer screening and risk assessment. Uses advanced liquid biopsy technology to identify epigenetic biomarkers associated with colorectal malignancy. Enables non-invasive early detection and personalized patient stratification for clinical decision-making.
Glycanostics, s.r.o. · Slovakia
Non-invasive liquid biopsy test for early-stage prostate cancer detection using glycan analysis in blood serum. Achieves up to 90% accuracy using magnetic particle-based technology with minimal blood sample requirement of 10 microliters.
i Med Laboratories Co., Ltd. · Thailand
Diagnostic test for detection of cancer biomarkers in blood and body secretions. Identifies biomolecules produced and released by cancer cells for screening and monitoring purposes.
CheMOnitor Ltd. · Hungary
An in vitro diagnostic blood test designed to predict chemotherapy effectiveness in lung cancer patients at an early stage, before full treatment cycles are completed. The test analyzes N-glycan profiles using ultra-high resolution glycomics combined with AI-based data interpretation to provide oncologists with actionable treatment response predictions.
Jiangsu Sunlant Bioengineering Co., Ltd. · China
A microarray chemiluminescence protein chip detection test kit for simultaneous detection of 7 tumor markers specific to lung cancer. The kit enables comprehensive lung cancer screening through high-throughput analysis using the platform's sandwich immunoassay methodology.
STRATEC/Diatron · Germany
In-vitro diagnostic test for detecting tumor markers and cancer-related antigens in blood and other biological samples. The test aids in cancer screening, diagnosis, and treatment monitoring.
Ease Healthcare · United States
Blood test for assessing lung cancer risk in vulnerable populations, including those with age or smoking history risk factors, enabling early detection and intervention.
GeneCker Co., Ltd. · South Korea
Molecular diagnostic test using CRISPR/Cas9 technology to identify and amplify mutant DNA sequences in patient samples. Provides standardized detection and quantification of cancer-related genetic mutations.
72 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products